Conference abstract · 20 Mar 2017
Conference abstractPublished 20 Mar 2017
IPSC derived MSC and MSC engineering
Q Therapeutics, Inc., USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Mesenchymal stem cells have been approved for therapy in multiple geographies and for multiple indications. However, manufacturing from an adult source has been a challenge for allogeneic use. We have proposed that MSC derived from IPSC may solve this sourcing issue and offer several advantages such as the ability to prospectively identify the right allelic phenotype and the possibility of genetically modifying the cells to enhance their utility.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Preparation of a standardized bank of iPSC-derived mesenchymalstem cells (MSC) engineered to deliver suicide genes into tumors
Case report · 24 Jan 2022
Adjustment of CD146 By MSC Development Media with Osteogenic Separation of Pmscs and Human Placenta-Derived Mesenchymal Stromal Cells
Conference abstract · 12 Sep 2016
Restoring the regenerative capacity of human bone marrow-derived mesenchymal stem cells (BM-MSCs) from the elderly to establish a high quality autologous MSC bank
Conference abstract · 1 Oct 2012
Adhesion to extracellular matrix-derived peptides can differentiate between human bone marrow derived mesenchymal stem cells and MSC-like pericytes
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectEngineering
- BylineArticles whose byline prints “Mahendra S.Rao”
